Search research articles
Contact Us
Filters
Showing results (691-700 of 725) with videos related to
Page
of 73
Sort By:
Cancer Discovery
|
February 19, 2014
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer
Elza C de Bruin, Catherine Cowell, Patricia H Warne, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors
Xiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, et al.
Anaesthesia, Critical Care & Pain Medicine
|
November 22, 2025
Cost-utility of point-of-care viscoelastic hemostatic assays in the management of bleeding during cardiac surgery: a single-blinded prospective multicenter stepped wedge cluster randomized trial in French context
Mickael Vourc'h, Elodie Boissier, Karim Lakhal, et al.
ACS Medicinal Chemistry Letters
|
September 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 Agonists
Nicholas R Wurtz, Pravin S Shirude, Daniel L Cheney, et al.
Pediatric Blood & Cancer
|
July 17, 2023
Return visit rates after an emergency department discharge for children with sickle cell pain episodes
Keli D Coleman, Kenneth McKinley, Angela M Ellison, et al.
Pediatric Blood & Cancer
|
May 3, 2025
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease
Keli D Coleman, Kenneth McKinley, Angela M Ellison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2023
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2018
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux, Scott N Gettinger, Grainne O'Kane, et al.
Medchemcomm
|
August 16, 2018
Triazolopyrimidines identified as reversible myeloperoxidase inhibitors
Franck Duclos, Lynn M Abell, David G Harden, et al.
JAMA Pediatrics
|
September 2, 2025
Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain
Ibrahim Gwarzo, Keli D Coleman, Kenneth McKinley, et al.
Page
of 73
Search research articles
Search
Showing results (691-700 of 725) with videos related to
Sort By:
Page
of 73
Cancer Discovery
|
February 19, 2014
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer
Elza C de Bruin, Catherine Cowell, Patricia H Warne, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors
Xiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, et al.
Anaesthesia, Critical Care & Pain Medicine
|
November 22, 2025
Cost-utility of point-of-care viscoelastic hemostatic assays in the management of bleeding during cardiac surgery: a single-blinded prospective multicenter stepped wedge cluster randomized trial in French context
Mickael Vourc'h, Elodie Boissier, Karim Lakhal, et al.
ACS Medicinal Chemistry Letters
|
September 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 Agonists
Nicholas R Wurtz, Pravin S Shirude, Daniel L Cheney, et al.
Pediatric Blood & Cancer
|
July 17, 2023
Return visit rates after an emergency department discharge for children with sickle cell pain episodes
Keli D Coleman, Kenneth McKinley, Angela M Ellison, et al.
Pediatric Blood & Cancer
|
May 3, 2025
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease
Keli D Coleman, Kenneth McKinley, Angela M Ellison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2023
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2018
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux, Scott N Gettinger, Grainne O'Kane, et al.
Medchemcomm
|
August 16, 2018
Triazolopyrimidines identified as reversible myeloperoxidase inhibitors
Franck Duclos, Lynn M Abell, David G Harden, et al.
JAMA Pediatrics
|
September 2, 2025
Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain
Ibrahim Gwarzo, Keli D Coleman, Kenneth McKinley, et al.
Page
of 73